According to the past studies, hypercholesterolemia or liver cholesterol accumulation were thought to be related to SREBP-2 and regulated by HMG-CoA reductase, which is the rate-limiting enzyme in cholesterol synthesis pathway [30,31]. This evidence concerns the gene SREBF2 and familial hypercholesterolemia.